We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Shares of CRISPR Therapeutics CRSP have lost more than 30% in the past year. Though the stock soared at the onset of 2024, ...

Vertex Pharmaceuticals (NASDAQ: VRTX) is a biotechnology company with a strong track record of success in developing ...

Brookline Capital Management boosted their FY2024 earnings per share estimates for CRISPR Therapeutics in a research note issued on Monday, January 6th. Brookline Capital Management analyst L. Cann ...

CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target lowered by Bank of America from $98.00 to $85.00 in ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Funeral services honoring former President Jimmy Carter, who died Sunday at age 100, will be held in Georgia and Washington, D.C., beginning Saturday, Jan. 4, and concluding Thursday, Jan. 9. Here ...

Among the most exciting breakthroughs are gene therapy and gene editing, with CRISPR-Cas9 leading the charge. This remarkable tool, inspired by bacteria’s natural defenses, acts like precise ...

We have now had all of the UK bank holidays listed for 2024 and, with many people set to return to work soon, it makes sense that some may be wondering when we can expect to be off in 2025.

Vor’s trem-cel therapy, which uses CRISPR/cas9 to edit the bone marrow of patients ... or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any ...